Yes this company is shitty. Good products but everything else is shitty. That is why JNJ divested it. This was not a hostile takeover as some have called it, JNJ decided it was no longer a business they wanted to be in based on the market. Bristol Myers ran the numbers and did the same thing with Convatec. Wound Care is a good market, however it is a market that is driven by pricing and cheap products. Nobody wins when it comes down to the cheapest products. That is why Systagenix is not growing. The products work but they are too costly for hospitals and since they have few contracts very few hospitals use our products on the inpatient side. Wound Centers yes but not in Acute. We know our Advanced products work and so do WOCN's and Doctors however when compared to shitty cheaper products (medline) these people cant justify the extra cost so they go with the shit. Sorry folks but this is true. JNJ and BMS realized this and got the fuck out of dodge. That is why we have less than 5% market share. Its funny that people thought JNJ was a leader in Wound Care because it was "JNJ". They didnt have market share either and never made budget as a division. This is why the business was never funded as part of Ethicon. It was viewed as a losing propostion.
Wound Care helps alot of people heal and is a good business but the way Systagenix manages this company and forgets that we are a disposable company and they have no idea how to compensate based on disposables and they keep thinking we are KCI then we will continue to have major issues. Off of soapbox, thank you.